Projected Growth of the Pressure Ulcer Market by 2032: Key Players...

Projected Growth of the Pressure Ulcer Market by 2032: Key Players and Insights

Posted 2024-10-18 07:52:27

The pressure ulcer market is poised for significant growth by 2032, with companies such as Phagelux, MiMedx, EyeGene, Shionogi, NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences, Baxter International, Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, B. Braun Melsungen, ConvaTec Group, and Coloplast Group anticipated to reshape the landscape. This is according to forecasts by DelveInsight.

To assist these companies in their development of effective treatments for pressure ulcers, DelveInsight has released a report titled “Pressure Ulcer Market Insight: Epidemiology and Market Forecast, 2032.” This comprehensive report provides an in-depth epidemiology-based market analysis, serving as a strategic roadmap for navigating the evolving pressure ulcer market.

Key Highlights from the Pressure Ulcer Market Report

Market Expansion: The pressure ulcer market is expected to experience growth throughout the study period, impacting the seven major markets (7MM).
Key Industry Players: Prominent companies in the market include Phagelux, MiMedx, EyeGene, Shionogi, NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences Holding Corporation, Baxter International Inc. (Hill-Rom Holdings Inc.), Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, B. Braun Melsungen AG, ConvaTec Group PLC, and Coloplast Group.
Increased Incidence Among Diabetic Patients: Pressure ulcers are more prevalent in individuals with diabetes, with an estimated 537 million adults in the 7MM affected, of which approximately 150 million experience ulcers at some point.
Lifetime Risk in the U.S.: Studies estimate that 10% of the U.S. population will experience pressure ulcers at some point in their lives.
Market Drivers: The surge in the pressure ulcer market is attributed to increasing disease prevalence and awareness, along with the introduction of various pipeline products that are expected to transform market dynamics.

Get a free sample of “Pressure Ulcer Market Report”

Treatment Analysis and Market Insights

The report includes an analysis of treatment regimens across the 7MM, enabling companies to evaluate current practices, the patient journey, and innovations in pressure ulcer therapies that can enhance treatment outcomes.

Pressure ulcers, also known as bedsores or pressure sores, occur due to localized injuries to the skin and underlying tissue resulting from prolonged pressure. They typically develop in individuals with limited mobility, forming over bony areas like the heels, hips, tailbone, and elbows. Factors influencing their development include pressure intensity, duration, and the individual’s overall health.

Preventative measures include regular repositioning, maintaining proper nutrition, utilizing specialized support surfaces, and ensuring good skin care. Timely detection and management are crucial to prevent worsening and to promote healing, with healthcare professionals implementing tailored treatment strategies such as wound care and infection control.

Epidemiological Insights and Future Forecasts

The report provides historical and forecasted epidemiological insights from 2019 to 2032, enabling a better understanding of the target patient population for pressure ulcers. This segmentation includes:

Total prevalence of pressure ulcers
Prevalent cases categorized by severity
Gender-specific prevalence
Diagnosed cases of episodic and chronic pressure ulcers

Emerging Therapies and Market Dynamics

The report highlights emerging therapies in development, including EGT 022 by EyeGene, a recombinant polypeptide derived from the human protein ADAM-15.

Recent advancements noted include:

In March 2021, Smith+Nephew reported that switching to ALLEVYN LIFE Foam Dressings reduced dressing change frequency and costs while improving clinician and patient satisfaction in a community setting.
In February 2021, Axis Biosolutions received European CE mark approval for MAxiCel, a wound care product for various chronic wounds, including pressure ulcers.

The dynamics of the pressure ulcer market are expected to shift in the coming years due to anticipated launches of emerging therapies like Thymosin Beta 4 and Ibuprofen during the forecast period (2019-2032). The rising prevalence of pressure ulcers, along with the shift in company focus toward this area, is expected to fuel market growth despite current low awareness of the condition.

Get a free sample of “Pressure Ulcer Market Report”

Strategic Insights for Stakeholders

DelveInsight’s report offers crucial insights, market analyses, and forecasts that can aid leading companies in making strategic decisions in the pressure ulcer market landscape.

Competitive Edge: Stakeholders can gain an understanding of the competitive environment, identify key companies developing pressure ulcer treatments, and analyze their strategies to gain a competitive advantage.
Identifying Market Gaps: By examining epidemiological trends and patient journeys, stakeholders can identify unmet needs in current treatments, paving the way for innovative therapeutic solutions.
Strategic Decision-Making: Insights from the report empower stakeholders to make informed decisions regarding research and development investments, portfolio expansions, pricing strategies, partnerships, and more.
Roadmap to Success: The report enables companies to establish short-term and long-term goals, outline market penetration strategies, and define steps for product development and market expansion.

About DelveInsight

DelveInsight is a leading healthcare business consultant and market research firm specializing in life sciences. The firm provides comprehensive solutions to pharmaceutical companies, enhancing their performance through detailed market analyses and consulting services aimed at fostering business growth and overcoming industry challenges.

Latest Reports

Please log in to like, share and comment!